EDTA chelation therapy in the treatment of vascular disease.
Ethylenediamine tetraacetic acid (EDTA) chelation therapy has been used for decades for the treatment of vascular disease, alone or in combination with other treatments. This article includes a historic review of the research literature, current evidence of effectiveness, potential mechanisms of action of EDTA, and some brief case reports. The authors conclude that EDTA chelation therapy is a valuable therapeutic option for vascular disease, either alone or in conjunction with standard treatment protocols.
Chappell
L T
LT
Wright State School of Medicine, Dayton, Ohio, USA.
Janson
M
M
D002614:Chelating Agents / Q000627:therapeutic use*; D015913:Chelation Therapy; D000529:Complementary Therapies; D004492:Edetic Acid / Q000627:therapeutic use*; D006801:Humans; D014652:Vascular Diseases / Q000188:drug therapy*
D002614:Chelating Agents; D004492:Edetic Acid